According to the latest report by IMARC Group, titled “Pen Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the Pen Needles Market Report to grow at a CAGR of XX% during 2021-2026.Pen needles are injector pens that are used for delivering medication into the body of a patient. They consist of hollow needles embedded in a plastic body that is connected to the injection pen. Pen needles are used by health professionals and patients who are suffering from diabetes. Nowadays, they are available in a variety of needle lengths and diameters. Pen needles are manufactured with fine and thin point tips made by electro-polishing the needles to offer ease of use and penetration. They also have plastic caps for safety and lubrication for easy glide and less friction.
Pen Needles Market Trends:
The pen needles market is primarily driven by the rising prevalence of chronic and lifestyle diseases like diabetes, osteoporosis, cardiovascular diseases, and multiple sclerosis. In addition, pen needles are cost-effective, portable, and do not require refrigeration for daily or weekly drug administration through pen injectors. Besides this, pen injectors are gaining popularity as the new standard for injectable drug delivery systems due to their simplicity, reliability, and the ability to be administered directly by the patient without the aid of a physician. Furthermore, factors such as the rising geriatric population, inflating healthcare expenditure, and favorable government policies are some of the other factors that are expected to significantly impact the market in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/pen-needles-market/requestsample
Pen Needles Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Menarini Diagnostics srl, Advancare Pharma, Arkray Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hindustan Syringes & Medical Devices Ltd., HTL Strefa SA, Novo Nordisk A/S, Owen Mumford Ltd., Simple Diagnostics, Trividia Health Inc. (Sinocare) and Ultimed Inc.
The report has segmented the market on the basis on region, disc type, material type and end user.
Breakup by Type:
Standard Pen Needles
Safety Pen Needles
Breakup by Needle Length:
4mm
5mm
6mm
8mm
10mm
12mm
Breakup by Therapy:
Insulin
GLP-1
Growth Hormones
Breakup by Mode of Purchase:
Retail
Non-Retail
Breakup by End User:
Hospitals and Clinics
Home Healthcare
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pen-needles-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.